Evy Vandemeulebroucke

2.1k citations

18 papers · 834 indexed · h-index 13

Genetics top 5%
Surgery top 5%
Endocrinology, Diabetes and Metabolism top 2%
Immunology
Molecular Biology

Co-authors: Daniël Pipeleers Bart Keymeulen Chantal Mathieu Frans Gorus Herman Waldmann Lucienne Chatenoud Christophe De Block Ilse Weets
Topics: Diabetes and associated disorders (15 papers)Pancreatic function and diabetes (12 papers)Diabetes Management and Research (12 papers)
Cited by: Endocrinology, Diabetes and Metabolism Genetics Surgery
Journals: Proceedings of the National Academy of Sciences Blood The Journal of Clinical Endocrinology & Metabolism
Partner nations: Belgium Netherlands Germany

In The Last Decade

Evy Vandemeulebroucke

18 papers receiving 787 citations

Peers

Countries citing papers authored by Evy Vandemeulebroucke

Since Specialization

Citations

This map shows the geographic impact of Evy Vandemeulebroucke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evy Vandemeulebroucke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evy Vandemeulebroucke more than expected).

Fields of papers citing papers by Evy Vandemeulebroucke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evy Vandemeulebroucke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evy Vandemeulebroucke. The network helps show where Evy Vandemeulebroucke may publish in the future.

Co-authorship network of co-authors of Evy Vandemeulebroucke

This figure shows the co-authorship network connecting the top 25 collaborators of Evy Vandemeulebroucke. A scholar is included among the top collaborators of Evy Vandemeulebroucke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evy Vandemeulebroucke. Evy Vandemeulebroucke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Clinical action measures improve the reliability of feedback on quality of care in diabetes centres: a retrospective cohort study 2016 ·BMC Health Services Research ·Astrid Lavens,Kris Doggen,Chantal Mathieu,Frank Nobels,Evy Vandemeulebroucke,(unknown),Ann Verhaegen,Viviane Van Casteren	2
2	Relationship between glycaemic variability and hyperglycaemic clamp-derived functional variables in (impending) type 1 diabetes 2015 ·Diabetologia ·(unknown),(unknown),(unknown),Eric V. Balti,Katelijn Decochez,Ilse Weets,Evy Vandemeulebroucke,Ursule Van de Velde,(unknown),(unknown),Christophe De Block,Johannes Ruige,Pieter Gillard,Bart Keymeulen,Daniël Pipeleers,Frans Gorus	16
3	Relation between glycemic variability, functional beta cell mass and glucose disposal rate in (pre)type 1 diabetes 2014 ·VUBIR (Vrije Universiteit Brussel) ·(unknown),(unknown),Eric V. Balti,Katelijn Decochez,Ilse Weets,Evy Vandemeulebroucke,Bart Keymeulen,Daniël Pipeleers,Frans Gorus	1
4	Hyperglycemic Clamp and Oral Glucose Tolerance Test for 3-Year Prediction of Clinical Onset in Persistently Autoantibody-Positive Offspring and Siblings of Type 1 Diabetic Patients 2014 ·The Journal of Clinical Endocrinology & Metabolism ·Eric V. Balti,Evy Vandemeulebroucke,Ilse Weets,Ursule Van de Velde,(unknown),(unknown),Katrijn Verhaeghen,Pieter Gillard,Christophe De Block,Johannes Ruige,Bart Keymeulen,Daniël Pipeleers,Katelijn Decochez,Frans Gorus,(unknown)	8
5	In antibody-positive first-degree relatives of patients with type 1 diabetes, HLA-A24 and HLA-B18, but not HLA-B39, are predictors of impending diabetes with distinct HLA-DQ interactions 2013 ·Diabetologia* ·(unknown),(unknown),Bart Van Der Auwera,Ilse Weets,Paul Van Crombrugge,Laurent Crenier,(unknown),(unknown),Katelijn Decochez,Evy Vandemeulebroucke,Pieter Gillard,Bart Keymeulen,Christiaan Van Schravendijk,Janet M. Wenzlau,John C. Hutton,Daniël Pipeleers,Frans Gorus	13
6	Preservation of recall immunity in anti‐CD3‐treated recent onset type 1 diabetes patients 2011 ·Diabetes/Metabolism Research and Reviews ·(unknown),Robert Hilbrands,Evy Vandemeulebroucke,Daniël Pipeleers,Herman Waldmann,Chantal Mathieu,Bart Keymeulen,Bart O. Roep	7
7	Pharmacokinetics and Antibody Responses to the CD3 Antibody Otelixizumab Used in the Treatment of Type 1 Diabetes 2010 ·The Journal of Clinical Pharmacology ·G Hale,(unknown),Ibrahim Al Bakir,Emma Bolam,Paweł Wiczling,William J. Jusko,Evy Vandemeulebroucke,Bart Keymeulen,Chantal Mathieu,(unknown),Lucienne Chatenoud,Herman Waldmann	41
8	Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass 2010 ·Diabetologia ·Bart Keymeulen,Melanie Walter,Chantal Mathieu,L. Kaufman,Frans Gorus,Robert Hilbrands,Evy Vandemeulebroucke,Ursule Van de Velde,Laurent Crenier,Christophe De Block,Sophie Candon,Herman Waldmann,A G Ziegler,Lucienne Chatenoud,Daniël Pipeleers	233
9	Functional β-Cell Mass and Insulin Sensitivity Is Decreased in Insulin-Independent Pancreas-Kidney Recipients 2009 ·Transplantation ·Pieter Gillard,Evy Vandemeulebroucke,Bart Keymeulen,Jacques Pirenne,Bart Maes,Pieter De Pauw,Yves Vanrenterghem,Daniël Pipeleers,Chantal Mathieu	18
10	Hyperglycaemic clamp test for diabetes risk assessment in IA-2-antibody-positive relatives of type 1 diabetic patients 2009 ·Diabetologia ·(unknown),Evy Vandemeulebroucke,Bart Keymeulen,Katelijn Decochez,Ilse Weets,Christophe De Block,Françoise Féry,Ursule Van de Velde,Ilse Vermeulen,Pieter De Pauw,Chantal Mathieu,Daniël Pipeleers,Frans Gorus	20
11	Insulin treatment in IA-2A-positive relatives of type 1 diabetic patients 2009 ·Diabetes & Metabolism ·Evy Vandemeulebroucke,Frans Gorus,Katelijn Decochez,Ilse Weets,Bart Keymeulen,Christophe De Block,(unknown),Daniël Pipeleers,Chantal Mathieu	31
12	Transient Epstein-Barr virus reactivation in CD3 monoclonal antibody-treated patients 2009 ·Blood ·Bart Keymeulen,Sophie Candon,Samira Fafi‐Kremer,Anette G. Ziegler,Marianne Leruez‐Ville,Chantal Mathieu,Evy Vandemeulebroucke,Markus Walter,Laurent Crenier,Éric Thervet,Christophe Legendre,Denis Piérard,G Hale,Herman Waldmann,Jean‐François Bach,J. M. Seigneurin,Daniël Pipeleers,Lucienne Chatenoud	67
13	Adiponectin levels do not predict clinical onset of type 1 diabetes in antibody-positive relatives 2007 ·Diabetologia ·(unknown),(unknown),Christiaan Van Schravendijk,Dieter De Smet,Katelijn Decochez,Evy Vandemeulebroucke,M. Giri,Bart Keymeulen,Chantal Mathieu,L. Van Gaal,Pieter De Pauw,Ilse Weets,Daniël Pipeleers,Frans Gorus,(unknown)	6
14	Correlation between β cell mass and glycemic control in type 1 diabetic recipients of islet cell graft 2006 ·Proceedings of the National Academy of Sciences ·Bart Keymeulen,Pieter Gillard,Chantal Mathieu,Babak Movahedi,Geert Maleux,Georges Delvaux,Dirk Ysebaert,Bart O. Roep,Evy Vandemeulebroucke,Miriam Marichal,Pieter In 'T Veld,Marika Bogdani,Christel Hendrieckx,Frans Gorus,Zhidong Ling,Jon van Rood,Daniël Pipeleers	142
15	Proinsulin levels and the proinsulin:c-peptide ratio complement autoantibody measurement for predicting type 1 diabetes 2005 ·Diabetologia ·(unknown),(unknown),Pieter De Pauw,P N Jørgensen,Christiaan Van Schravendijk,(unknown),Katelijn Decochez,Evy Vandemeulebroucke,Ilse Weets,Ruifeng Mao,Daniël Pipeleers,Frans Gorus	64
16	Combined positivity for HLA DQ2/DQ8 and IA-2 antibodies defines population at high risk of developing type 1 diabetes 2005 ·Diabetologia ·(unknown),Katelijn Decochez,(unknown),Bart Van Der Auwera,Ilse Weets,Evy Vandemeulebroucke,Ivo H. De Leeuw,Bart Keymeulen,Chantal Mathieu,R. Rottiers,Daniël Pipeleers,Frans Gorus	37
17	IA-2 autoantibodies predict impending Type I diabetes in siblings of patients 2002 ·Diabetologia ·Katelijn Decochez,I. De Leeuw,Bart Keymeulen,Chantal Mathieu,R. Rottiers,Ilse Weets,Evy Vandemeulebroucke,(unknown),L. Kaufman,Frans Schuit,Daniël Pipeleers,Frans Gorus	74
18	Silent iodine prophylaxis in Western Europe only partly corrects iodine deficiency; the case of Belgium 2000 ·European Journal of Endocrinology ·François Delange,Anne Van Onderbergen,Wael Shabana,Evy Vandemeulebroucke,F. Vertongen,(unknown),M. Dramaix	54

About Evy Vandemeulebroucke

Evy Vandemeulebroucke is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery, having authored 18 papers that have together received 834 indexed citations. Recurring topics across this work include Diabetes and associated disorders (15 papers), Pancreatic function and diabetes (12 papers) and Diabetes Management and Research (12 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (591 citations), Genetics (631 citations) and Surgery (614 citations). Evy Vandemeulebroucke has collaborated with scholars based in Belgium, Netherlands and Germany. Frequent co-authors include Daniël Pipeleers, Bart Keymeulen, Chantal Mathieu, Frans Gorus, Herman Waldmann, Lucienne Chatenoud, Christophe De Block, Ilse Weets, Katelijn Decochez and Laurent Crenier. Their work appears in journals such as Proceedings of the National Academy of Sciences, Blood and The Journal of Clinical Endocrinology & Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact